WHO-GMP Certified Commercial Pack · Product Code: AKP-074
Zolmitriptan 5.0% w/v Nasal Spray
Formulation Overview: Fast-acting selective 5-HT1B/1D agonist intranasal spray bypassing gastric stasis during migraine nausea to achieve headache relief within 15 minutes via direct nasopharyngeal absorption. Formulated with Zolmitriptan 5.0% w/v (5 mg per 0.1 ml actuation) (5.0% w/v (5 mg/spray)) in Metered-Dose Anti-Migraine Nasal Spray dosage form under Pain, Inflammation & NSAIDs, manufactured to IP / BP / USP Compendial standards and supplied in Unit-Dose / Multi-Dose Metered Nasal Spray Device in Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-074 |
|---|---|
| Therapeutic Sector | Pain, Inflammation & NSAIDs |
| Dosage Form | Metered-Dose Anti-Migraine Nasal Spray |
| Active Ingredient | Zolmitriptan 5.0% w/v (5 mg per 0.1 ml actuation) |
| Strength / Purity | 5.0% w/v (5 mg/spray) |
| Clinical Indication | Acute migraine attacks with or without aura and cluster headaches requiring rapid non-oral onset |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | Unit-Dose / Multi-Dose Metered Nasal Spray Device in Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from heat and direct light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |